Name | 6-(Bromomethyl)pteridine-2,4-diamine hydrobromide (1:1) |
Synonyms | 2,4-diamino-6-(bromomethyl)pteridine 6-BROMOMETHYL-PTERIDINE-2,4-DIAMINE HBR 6-Bromomethyl-Pteridine-2,4-Diamine Hbr 2, 4-diaMino-6-(broMoMethyl)-pteridine HCL 6-(Bromomethyl)-2,4-diaminopteridine Hydrobromide 2,4-Diamino-6-(bromomethyl)pteridine Hydrobromide 2,4-pteridinediaMine, 6-(broMoMethyl)-, hydrobroMide 2,4-diamino-6-(bromomethyl)pteridine(for methotrexate) 2,4-PteridinediaMine, 6-(broMoMethyl)-, MonohydrobroMide 6-(BroMoMethyl)-2,4-pteridinediaMine HydrobroMide (Technical Grade) |
CAS | 52853-40-4 |
EINECS | 692-499-2 |
InChI | InChI=1/C7H7BrN6.BrH/c8-1-3-2-11-6-4(12-3)5(9)13-7(10)14-6;/h2H,1H2,(H4,9,10,11,13,14);1H |
Molecular Formula | C7H8Br2N6 |
Molar Mass | 335.98662 |
Melting Point | >195°C (dec.) |
Boling Point | 524.7°C at 760 mmHg |
Flash Point | 271.1°C |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Vapor Presure | 1.6E-11mmHg at 25°C |
Appearance | Solid |
Color | Light Brown to Brown |
Storage Condition | -20°C Freezer |
Use | This product is for scientific research only and shall not be used for other purposes. |
application | 6-(bromomethyl)-2,4-pteridine diamine hydrobromide can be used as an organic synthesis intermediate and pharmaceutical intermediate, mainly used in laboratory research and development process and chemical and pharmaceutical production process. |